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Satellite cells are skeletal muscle stem cells capable
of self-renewal and differentiation after transplanta-
tion, but whether they contribute to endogenous
muscle fiber repair has been unclear. The transcrip-
tion factor Pax7 marks satellite cells and is critical
for establishing the adult satellite cell pool. By using
a lineage tracing approach, we show that after injury,
quiescent adult Pax7+ cells enter the cell cycle; a
subpopulation returns to quiescence to replenish
the satellite cell compartment, while others con-
tribute to muscle fiber formation. We demonstrate
that Sprouty1 (Spry1), a receptor tyrosine kinase
signaling inhibitor, is expressed in quiescent Pax7+
satellite cells in uninjured muscle, downregulated in
proliferating myogenic cells after injury, and rein-
duced as Pax7+ cells re-enter quiescence. We
show that Spry1 is required for the return to quies-
cence and homeostasis of the satellite cell pool
during repair. Our results therefore define a role for
Spry1 in adult muscle stem cell biology and tissue
repair.
INTRODUCTION
Reversible quiescence is widely accepted to be a defining prop-
erty of adult stem cells. The ability of adult stem cells to transition
to a reversible quiescent state after providing a source of
progeny is critical for homeostasis of tissue-resident stem cells
and presumably the maintenance of the tissue during numerous
rounds of damage caused by various insults throughout life.
Adult skeletal muscle satellite cells (skeletal muscle stem cells)
are located between the muscle fiber sarcolemma and the basal
lamina surrounding the fiber and are major contributors to the
maintenance and repair of postnatal skeletal muscle tissue. In
uninjured muscle, satellite cells reside in a quiescent state andCexpress the paired-box protein Pax7, a critical regulator of satel-
lite cell survival and required for muscle tissue homeostasis
(Seale et al., 2000; Oustanina et al., 2004; Kuang et al., 2006;
Relaix et al., 2006). Transplantation studies have demonstrated
that a subpopulation of satellite cells are capable of both self-
renewal and differentiation during muscle tissue repair (Montar-
ras et al., 2005; Collins et al., 2005; Kuang et al., 2007; Sacco
et al., 2008; Cerletti et al., 2008). However, the mechanism by
which a subset of satellite cells or their progeny bypasses cues
to differentiate and instead return to quiescence to replenish
the quiescent adult muscle stem cell pool, i.e., self-renew, during
the regeneration process remains incompletely understood.
Receptor tyrosine kinase (RTK) signaling is critical for many
processes during development and regeneration including
myogenic fate decisions (Johnson et al., 1994; Poss et al.,
2000; Lee et al., 2005; Abou-Khalil et al., 2009). RTK ligands
such as FGF and HGF are potent activators of muscle satellite
cells (Yablonka-Reuveni et al., 1999; Sheehan and Allen, 1999;
Jones et al., 2001). The activity of these signaling pathways is
tightly controlled by the action of feedback regulators. One
downstream target and negative regulator of RTK signaling is
Sprouty (Spry) (Hanafusa et al., 2002; Kim and Bar-Sagi, 2004;
Mason et al., 2006). The mouse and human genomes contain
four Spry genes (Spry1-Spry4). In Drosophila, Spry is required
for cell fate determination in many settings (Reich et al., 1999;
Kramer et al., 1999; Casci et al., 1999). Recent gain-of-function
experiments demonstrated that Spry2 promoted a shift in fate
of myogenic cells, favoring a less-differentiated Pax3/7-express-
ing population at the expense of a more differentiated myogenin-
expressing population during embryonic myogenesis (Lagha
et al., 2008). Microarray data suggested that quiescent adult
satellite cells express high levels of Spry1 with the other Spry
family members present at much lower levels (Fukada et al.,
2007). Importantly, Spry1 expression was found to be downre-
gulated in cycling myogenic progenitors, raising the possibility
that Spry1 normally inhibits the RTK signals required for the
proliferation of these cells.
We used genetic lineage tracing to determine whether the
quiescent adult Pax7 cell is capable of replenishing the renewed
satellite cell pool and contributing to myofiber regeneration. Inell Stem Cell 6, 117–129, February 5, 2010 ª2010 Elsevier Inc. 117
Figure 1. The Pool of Quiescent Pax7 Satel-
lite Cells Returns to Homeostasis during
Adult Muscle Regeneration
(A) Transverse sections of uninjured (0 days after
injury) and regenerating (4, 12, and 50 days after
injury) TA muscle contain quiescent (MyoD,
Ki67) (green arrowhead) and cycling (MyoD+,
Ki67+; yellow arrowhead) Pax7+ cells in sublami-
nar location (laminin+; magenta). Differentiating
myogenic cells (red arrowhead) could be observed
in regenerating muscle underneath the basal
lamina.
(B) Total number of Pax7+ cells (left) and quiescent
(Ki67; MyoD) Pax7+ cells (right) per muscle
section from 4–6 mice per time point
(mean ± SEM; p < 0.05).
(C) BrdU+/Pax7+ cells in transverse sections from
fully regenerated muscle from BrdU-treated
mice. Top: Pax7 (red) and DAPI (blue) staining,
Bottom: BrdU (green) and DAPI staining. Regener-
ated muscle fibers are distinguished with DAPI+
central nuclei (white arrowhead). The contour of
muscle fiber is denoted by white line.
Scale bars represent 40 mm in (A) and 80 mm in (C).
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Sprouty1 and Reversible Muscle Stem Cell Quiescenceaddition, we sought to determine whether Spry1 is required for
homeostasis of the endogenous adult Pax7 satellite cell pool in
their native environment during muscle regeneration. We show
that the endogenous population of adult Pax7 cells is capable
of replenishing the satellite cell pool and expands to provide
a source of differentiated progeny contributing to muscle fiber
repair. Investigation into the role of Spry1 revealed that appro-
priate regulation of reversible quiescence is essential for self-
renewal of the adult Pax7-expressing satellite cell pool during
muscle regeneration.
RESULTS
Endogenous Adult Pax7 Cells Function as Muscle
Stem Cells within Their Native Environment
during Regeneration
Pax7 is a marker of adult satellite cells and is required for the
formation of the adult satellite cell pool (Seale et al., 2000; Ous-
tanina et al., 2004). The ability of adult skeletal muscle to undergo
numerous rounds of repair after injury suggests that self-renewal
occurs and homeostasis of the adult muscle satellite cell pool is
restored or otherwise maintained during muscle regeneration
after injury. To test this, we quantified the number of Pax7+ cells
within adult skeletal muscle during regeneration. Tibialis Ante-
rior/Extensor Digitorus Longus (TA/EDL) muscle was injected
with 50 ml of 1.2% barium chloride and left to regenerate from
4 to 50 days (Figure 1A; Figure S1 available online). Immunohis-
tochemical analysis revealed a transient expansion of the
number of cycling (MyoD+/Ki67+) (Zammit et al., 2004; Sacco
et al., 2008) Pax7+ cells and a diminished quiescent (MyoD/
Ki67) Pax7+ pool between 4 and 12 days after injury compared
to uninjured muscle (Figure 1B). Between 30 and 50 days after
injury, the quiescent pool of Pax7+ cells, which represented
98% of the total Pax7 pool, returned to homeostatic levels that
were observed in uninjured muscle. To determine whether118 Cell Stem Cell 6, 117–129, February 5, 2010 ª2010 Elsevier Inc.Pax7+ cells that reoccupy the satellite cell position in regener-
ated fibers had previously cycled, BrdU was administered during
the first 7 days of regeneration and analyzed in Pax7+ cells.
Muscle sections from fully regenerated muscle showed that
98% ± 0.4% of quiescent Pax7+ cells (1493/1500, n = 4 mice)
had incorporated and retained BrdU and therefore had previ-
ously cycled (BrdU+) during regeneration (Figure 1C). In contrast,
Pax7+ cells in uninjured muscle did not have detectable BrdU
(data not shown). This demonstrates that under the injury para-
digm used in the present study, the quiescent Pax7+ satellite
cell pool homogeneously enters the cell cycle during repair and
that both the quiescent state and the size of the Pax7+ satellite
cell pool have been fully restored to that of uninjured muscle
upon completion of muscle repair. This suggests that the quies-
cent Pax7+ satellite cell pool is reversibly quiescent and is under
homeostatic control during muscle regeneration. However, this
type of analysis cannot exclude the possibility that Pax7+ satel-
lite cells in repaired muscle are derived from another source that
subsequently acquired a Pax7 phenotype.
To investigate directly whether quiescent adult Pax7+ satellite
cells have stem cell properties that enable self-renewal and
therefore both return to quiescence as well as contribute to
muscle fiber formation (differentiation) in their endogenous envi-
ronment, we used mice with an inducible Pax7-CreERtm (Nishijo
et al., 2009) and a R26R-lacZ (Soriano, 1999) reporter to genet-
ically lineage trace adult Pax7+ cells. Tamoxifen (TM) was admin-
istered to induce gene recombination and permanently express
b-gal in Pax7+ cells and their progeny. TA/EDL muscles from one
leg were injured and left to regenerate and the contralateral leg
remained uninjured (Figure 2A). In transverse sections from the
uninjured muscle, X-gal reactivity was observed in mononucle-
ated cells located in the satellite cell position. In the regenerating
muscle, X-gal reactivity was observed in small, de novo muscle
fibers but not in adjacent uninjured fibers. This suggests that
adult Pax7-derived satellite cells are able to contribute to muscle
Figure 2. Pax7-Derived Satellite Cells Are
Capable of Self-Renewal and Differentiation
(A) The cartoon depicts the tamoxifen (TM) injec-
tion scheme for lineage tracing muscle satellite
cells. Pax7+ satellite cells in the Pax7-
CreERtm;R26R-lacZ mouse were permanently
labeled by i.p. administration of TM 14 days prior
to muscle injury.
(B) Transverse sections were collected from unin-
jured and regenerating muscle and stained with
X-gal. Five days after injury, noncentrally nucle-
ated fibers in regenerating muscle had no detect-
able X-gal reactivity (*). After 50 days of regenera-
tion, X-gal+ mononucleated cells were observed in
the satellite cell position of regenerated muscle
fibers (black arrows).
(C) Single fibers from uninjured and regenerated
Pax7-CreERtm;R26R-lacZ muscle stained with
Pax7 (red), b-gal (green), and DAPI (blue). Regen-
erated muscle fibers are characterized by DAPI+
‘‘central-myonuclear chains.’’
(D) The percentage of b-gal+/Pax7+ satellite cells
expressing on single fibers isolated from uninjured
and regenerated muscle fibers in the presence (+)
or absence () of Cre or TM. Data are presented as
mean ± SEM. n = 4–6 mice (p < 0.05).
Scale bars represent 60 mm in (B, left), 30 mm in
(B, right), and 40 mm in (C).
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Sprouty1 and Reversible Muscle Stem Cell Quiescencedifferentiation in vivo. Fifty days after injury, X-gal+ mononucle-
ated cells were readily detected in the satellite cell position of re-
generated (centrally nucleated) muscle fibers (Figure 2B).
Because confirmation that b-gal expression was a readout of
Pax7-derived satellite cells, immunohistochemical analyses
from isolated single muscle fibers from TM-treated Pax7-
CreERtm;R26R-lacZ mice showed that b-gal expression was
observed in 84% and 87% of Pax7+ satellite cells from unin-
jured and regenerated muscle, respectively (Figures 2C and 2D).
Together, these data suggest that adult Pax7+ cells are capable
of self-renewal and differentiation in their endogenous environ-
ment and are sufficient to replenish the satellite cell pool in the
regenerating muscle.
Sprouty1 Expression Is Restricted to Noncycling Pax7
Satellite Cells
Because RTK/MAPK signaling has been implicated in the
process of quiescence and self-renewal (Jones et al., 2005;
Abou-Khalil et al., 2009), we characterized the expression
dynamics of a candidate gene, Spry1 (Sprouty1), which encodes
a RTK/MAPK regulator (Kim and Bar-Sagi, 2004) and is abun-
dantly expressed in muscle satellite cells (Fukada et al., 2007).
Myogenic cells were obtained by fluorescent activated cell sort-
ing (FACS) from uninjured and regenerating adult muscle (Fig-
ure 3A; Figure S2). Spry1 transcript was abundantly expressed
in myogenic cells isolated from uninjured (0 days) and regener-Cell Stem Cell 6, 117–129ated (20 and 50 days) muscle, when
most myogenic cells are noncycling
(Figures 3A and 1A; Figure S2). Spry1
levels were reduced in myogenic cells
isolated from muscle tissue at 2, 6, and
12 days after injury, when myogenic cellsare proliferating or differentiating (Figures 3A and 1A; Figure S2).
Therefore, Spry1 expression in myogenic cells is temporally
correlated with a quiescent state and is downregulated during
the proliferative phase of muscle regeneration. To characterize
Spry1 expression in muscle on a cell-by-cell basis, we analyzed
mice carrying one copy of aSpry1-lacZ knockin allele (Spry1lacZ/+)
(Thum et al., 2008) as a readout of Spry1 expression. In muscle
sections from uninjured adult mice, X-gal+ cells were primarily
detected in the characteristic satellite cell position (Figure 3B).
Single muscle fibers isolated from Spry1lacZ/+ muscle were fixed
immediately (0 hr) or cultured for 36 hr to activate satellite cells
(Zammit et al., 2004). b-gal was expressed in 92% of Pax7+ cells
(n = 184/197) at 0 hr and in only 8% (n = 16/202) of activated
(MyoD+) satellite cells after 36 hr in culture. We next analyzed
b-gal expression in Pax7+ satellite cells of Spry1lacZ/+ muscle
during muscle regeneration in vivo (Figure 3C). Spry1 as deter-
mined by b-gal expression was robustly expressed in Pax7+ cells
when they are primarily quiescent in uninjured muscle or return-
ing to quiescence during muscle regeneration (Figures 3D and
1B; Figure S2). These results confirmed that Spry1 expression
was restricted to Pax7+ cells when they are in a quiescent state.
Sprouty1 Is Required for Self-Renewal of the Quiescent
Pax7-Derived Satellite Cell Pool during Regeneration
Having established that Cre expression was induced in resting
adult satellite cells and could be used to follow cell fate in, February 5, 2010 ª2010 Elsevier Inc. 119
Figure 3. Sprouty1 Is a Marker of Quiescent Pax7+ Satellite Cells
(A) Relative Spry1 transcript levels assessed by real-time qRT-PCR from FACS-purified myogenic cells (see Figure S3 for FACS sorting and Ct values) isolated
from uninjured and regenerating muscle.
(B) Transverse sections and single muscle fibers from uninjured muscles of Spry1lacZ/+ mice were stained with X-gal (top). X-gal+ mononucleated cells (blue; black
arrows) were observed in the satellite cell position in muscle sections (left) and single fibers (right). Single fibers from Spry1lacZ/+ mice were stained with anti-b-gal
(green) and Pax7 (red) (middle; white arrows) or b-gal (green) and MyoD (red) (bottom; white arrowhead) after 0 hr or 36 hr in culture. Inset show b-gal+/Pax7+ cell
(middle) and b-gal/MyoD+ cell (bottom).
(C) Muscles from Spry1lacZ+/ were injured and left to regenerate from 4 to 50 days or remained uninjured. Muscle sections stained with anti-Pax7 and b-gal is
shown from uninjured and regenerating muscle. Arrows show Pax7+/b-gal+ cells (at 0 and 30 days after injury) and Pax7+/b-gal cells (at 12 days after injury).
(D) Quantitation of (C), showing the percentage of b-gal+/Pax7+ cells in muscle sections. Data were presented as mean ± SEM. n = 4–6 mice.
Scale bar represents 80 mm in (B) and 40 mm (C).
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Sprouty1 and Reversible Muscle Stem Cell Quiescencecombination with a reporter gene, we employed this system to
determine the molecular regulators of satellite cell self-renewal
and homeostasis. To directly test the role of Sprouty1 in Pax7+
satellite cells during muscle regeneration, we produced Pax7-
CreERtm;Spry1flox/flox;R26R-lacZ (termed satellite cell-specific
null [SC null]) mice to permanently disrupt Spry1 function in adult
Pax7+ satellite cells upon the administration of TM. Pax7-
CreERtm;Spry1WT/WT;R26R-lacZ mice treated with TM were
used as controls. A high degree of recombination was evident
in FACS-purified myogenic cells from SC null mice based on
expression of the R26R-lacZ reporter (89% X-gal+/myogenic
cells) and disruption of Spry1 at both the gene and transcription
level (Figure S3). To determine whether Spry1 was required for
the return to quiescence of the Pax7 satellite cell pool after
muscle injury, the total number of Pax7+ cells and their cycling
status, based on MyoD and Ki67 immunohistochemistry, were120 Cell Stem Cell 6, 117–129, February 5, 2010 ª2010 Elsevier Inc.determined in TA/EDL muscles from control and SC null mice
that were injured and allowed to regenerate for 50 days. Contra-
lateral muscles that remained uninjured served as internal
controls. In control animals, the presence of Cre or activation
of Cre by TM did not change the number of Pax7+ cells in the
regenerated muscle compared to the uninjured contralateral
muscles (Figure 4A), indicating that muscle stem cell homeo-
stasis was restored after muscle injury as shown previously
(Figure 1A). However, in SC null muscle, there was a 40% decline
in the number of Pax7+ satellite cells after 50 days of regenera-
tion compared to the uninjured contralateral muscle and the
regenerated control muscles (Figure 4A), suggesting that Spry1
is essential for homeostasis of the replenished satellite cell
pool. To test whether the remaining Pax7+ cells in SC null regen-
erated muscle were not targeted by Cre or had arisen from a non-
Pax7 origin, we quantified b-gal expression that represented
Figure 4. Sprouty1 Is Required for Restoring the Muscle
Stem Cell Pool during Regeneration
(A) Mice were injected with TM to permanently activate Cre in
Pax7-CreERtm;Spry1flox/flox; R26R-lacZ (SC null) and Pax7-
CreERtm;Spry1WT/WT;R26R-lacZ (control) adult mice. 14 days after
TM treatment, TA/EDL muscles from one leg were injured and left
to regenerate for 50 days. Muscle sections stained with anti-Pax7,
MyoD, Ki67, laminin, and DAPI (top panel is shown from control
and SC null regenerated muscle; white arrowheads denote subla-
minar Pax7 cells). Graphs (bottom) present the average number of
Pax7+ cells in sublaminar position. The bar between each point
defines each animal (p < 0.01). Scale bar represents 40 mm.
(B) Single muscle fibers from (A) were stained with anti-Pax7 and
b-gal to quantify the percentage of Pax7+ cells expressing b-gal
driven from the Pax7-Cre reporter.
(C) BrdU was administered in (A) during first 10 days after muscle
injury. Muscle sections were stained with anti-BrdU, Pax7, and
laminin. Histogram shows the percentage of BrdU+/Pax7+ cells
satellite cells after 50 days of regeneration.
(D) Muscle sections from Spry1+/+ and Spry1lacZ/lacZ were stained
with anti-Pax7, MyoD, Ki67, and laminin (see A). Graphs show the
average number of Pax7+ cells in sublaminar position in uninjured
and regenerated muscle sections of individual mice. The bar
between each point defines each animal.
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Sprouty1 and Reversible Muscle Stem Cell QuiescencePax7-Cre activity prior to muscle injury. In regenerated control
and SC null muscles, 87% and 88% of Pax7+ cells were
b-gal+, respectively, confirming that the majority of the replen-
ished Pax7+ satellite cell pool was derived from cells of a Pax7
origin (Figure 4B). In uninjured muscle, Spry1 disruption does
not lead to a loss of Pax7+ satellite cells; therefore, we tested
whether the remaining Pax7+ cells in the regenerated SC null
muscle responded to the injury stimulus by entering the cell
cycle. In both control and SC null muscle, 90% of Pax7+ cells
that replenished the satellite cell niche of the regenerated muscleCell Stem Cehad entered the cell cycle during regeneration as indi-
cated by BrdU incorporation (Figure 4C) and had
subsequently returned to quiescence (97% ± 4%
and 98% ± 1% of Pax7+ cells were MyoD/Ki67 in
control and SC null muscle, respectively). To confirm
that the complete loss of Spry1 would result in
a reduced pool of Pax7+ satellite cells after injury, we
injured adult muscles from Spry1lacZ/lacZ mice that
lack Spry1 protein (Figure S4) and their control litter-
mates, Spry1+/+. Fifty days after injury the number of
Pax7+ satellite cells in Spry1lacZ/lacZ was reduced by
50% compared toSpry1+/+ controls (Figure 4D). These
results indicate that homeostasis of the quiescent
satellite pool in the absence of Spry1 is not fully
restored after injury and that Spry1 is essential for
self-renewal of approximately half of the Pax7-derived
muscle stem cell pool during muscle regeneration.
Sprouty1 Regulates a Balance between
Reversible Quiescence and Apoptosis
A failure of satellite cells to return to quiescence in the
absence of Spry1 may be due to either an inability to
fully expand the pool of cycling Pax7 cells or to alter
the fate of these cells during regeneration from a
self-renewing fate to differentiation or apoptosis. Totest this, TA/EDL muscle from TM-treated control and SC null
mice were injected and left to regenerate for 13 days. Muscle
sections were analyzed for the number of Pax7+ cells and differ-
entiated myogenic cells. In SC null muscle, the percentage of
quiescent Pax7+ cells was reduced by 40%, whereas the
percentage of cycling Pax7+ cells and differentiated (Myogenin+)
cells was not altered compared to control muscles (Figure 5A;
Figure S5). We next analyzed the number and size of muscle
fibers as well as the number of apoptotic myogenic cells in unin-
jured and regenerating muscle from control and SC null mice.ll 6, 117–129, February 5, 2010 ª2010 Elsevier Inc. 121
Figure 5. Disruption of Spry1 in Pax7 Cells Affects Apoptosis but Not Differentiation of Myogenic Cells during Regeneration
(A) Quantitative analysis of regenerating muscle (13 days after injury) from TM-treated Pax7-CreERtm;Spry1WT/WT (control) and Pax7-CreER;Spry1flox/flox (SC null)
mice. Graph shows the average number of quiescent (MyoD, Ki67) (left) and cycling (MyoD+, Ki67+) (middle) Pax7+ cells and differentiated myogenic cells
(Myogenin+) (right) in serial sections of TA muscle. Cell counts are expressed relative to control muscle. Data were averaged (n = 3 mice per group) and expressed
as mean ± SEM (p < 0.05).
(B) Quantitative analysis of uninjured and regenerated muscle from TM-treated control and SC null mice. Graph shows the average muscle fiber cross-sectional
area (top) and the total number of muscle fibers (bottom) of uninjured and regenerated muscle in serial sections from the mid-belly of TA muscle.
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Sprouty1 and Reversible Muscle Stem Cell QuiescenceThe total cross-sectional area of muscle, the total number of
muscle fibers (Figure 5B), and the average muscle fiber size
were not different between SC null and control muscles at either
20 or 50 days after injury compared to regenerating control
muscle (Figure 5C), suggesting that Pax7+ cells with disrupted
Spry1 function were not favoring differentiation at the expense
of stem cell homeostasis and that Spry1 was not required for
myogenic differentiation in vivo. In contrast, there was an
increased number of apoptotic myogenic cells (TUNEL+/
MyoD+) in SC null compared to control regenerating muscle
analyzed 20 days after injury (Figure 5D). Therefore, Sprouty1
is essential for self-renewal and homeostasis of the quiescent
satellite cell pool but dispensable for muscle fiber differentiation
during regeneration.Sprouty1 Is Required for Myogenic Progenitors
to Return to Quiescence
The time-course of Spry1 gene expression during regeneration
indicated that Spry1 is rapidly downregulated in cycling satellite
cells after injury and is induced again 12 days after injury coin-
ciding with the re-emergence of the quiescent phenotype of
Pax7+ satellite cells (Figures 1 and 3). We therefore asked
whether Spry1 was required for returning a subset of cycling
myogenic cells to quiescence. By using single muscle fiber
suspension cultures, we analyzed the number of muscle-fiber-
resident Pax7+ cells that returned to quiescence (requiescence)
after cycling (i.e., self-renew) (Zammit et al., 2004). The total
number of Pax7+ cells per single muscle fiber was not different
between TM-treated SC null cultures and control muscle fiber
cultures (Figure S6). In contrast, the number of quiescent
Pax7+ cells per fiber was reduced by 50% in SC null compared
to control cultures. These data provide evidence that Spry1 is
required for reversible quiescence of a subpopulation of Pax7+
cells. We next examined the role of Spry1 in regulating requies-
cence of satellite cell progenitors by using an in vitro ‘‘reserve’’
cell preparation (Figure 6; Yoshida et al., 1998; Perez-Ruiz
et al., 2008). Low passage primary myoblasts from Spry1flox/flox
and Spry1WT/WT muscle were infected with Cre or control adeno-
virus, left to recover for 24 hr, and switched to low-serum
conditions for 3.5 days. This method reliably achieved 97%
infection/recombination efficiency (Figure S7). Based on immu-
nocytochemistry, myogenic cells in low serum cultures were
characterized as quiescent (Pax7+, MyoD, and Ki67),
apoptotic (Activated-Caspase-3+), and differentiated (Myoge-
nin+) (Figure 6A). After 3.5 days in culture, the percentage of
quiescent myogenic cells decreased and the percentage of
apoptotic cells increased in Cre-infected Spry1flox/flox cells
(Spry1Null) compared to Cre-infected Spry1WT/WT cells (control,
Figure 6B) and cells treated with control virus (data not shown).
Neither the percentage of cells expressing the differentiation
marker Myogenin nor their ability to fuse was altered by disrup-(C) TM-treated control (Pax7-CreERtm;Spry1WT/WT) and SC null (Pax7-CreERtm;S
Histogram shows the average muscle fiber size in uninjured and regenerated mu
(D) Control and SC null muscles described in (C) were stained for TUNEL (green), M
perilaminar position (white arrowheads). Inset: TUNEL+/MyoD+ nucleus (yellow) lo
head). Histogram (right) shows the number of TUNEL+, MyoD+ (yellow), and MyoD
expressed as mean ± SEM (p < 0.05).
Scale bars represent 80 mm.
Ction of Spry1 (Figure 6C). This observation supports our hypoth-
esis that Spry1 is essential for a subset of myogenic progenitors
to return to a quiescent state, while Spry1 appears redundant
for myogenic differentiation. Furthermore, cells expressing the
activated form of Caspase-3 were almost exclusively restricted
to the MyoD+/Myogenin population of progenitor cells, sug-
gesting that a cell fate decision between requiescence and
apoptosis occurs in myogenic progenitors prior to committing
to terminal differentiation.
Consistent with Spry’s role as an inhibitor of ERK signaling
(Kim and Bar-Sagi, 2004), we observed that ERK signaling was
upregulated in myogenic cells lacking Spry1 (Figure S4). We
tested whether the inability of cycling myogenic cells to return
to quiescence in the absence of Spry1 (as shown in Figure 6B)
was due to elevated ERK signaling. Cre adenovirus-treated
Spry1flox/flox (Spry1Null) and Spry1WT/WT (control) cultures were
incubated in low-serum conditions to generate ‘‘reserve’’ cells,
in the presence or absence of the MEK inhibitor U0126. After
3 days in culture, cells were fixed and analyzed for their quies-
cence immunophenotype (Figure 6D). The percentage of quies-
cent cells increased in Spry1Null cells in the presence of the MEK
inhibitor. Moreover, the percentage of quiescent cells in Spry1-
Null cultures treated with U0126 was indistinguishable from
control virus-treated Spry1WT/WT cells in the absence of U0126.
Together, this suggests that ERK signaling regulates cell fate
decisions involving reversible quiescence and that Sprouty1
functions primarily through an ERK-dependent signaling
cascade to regulate myogenic progenitor requiescence.Sprouty1 Regulates Homeostasis of the Self-Renewing
Satellite Cell Pool through a Subset of Cycling
Pax7-Derived Satellite Cells
Our data so far suggest that Spry1 function is required to main-
tain the quiescent stem cell pool during muscle repair. We next
wanted to test directly whether Spry1 was required for cycling
Pax7 satellite cells to re-establish the quiescent Pax7+ satellite
cell pool back to homeostasis during regeneration. We first
determined whether satellite cells that reoccupy the satellite
cell position in regenerated muscle are from a previously cycling
population. When BrdU was administrated from 0 to 7 days after
injury, there were 98% of Pax7+ cells retaining BrdU label
in fully regenerated TM-treated control and SC null muscle
(490 Pax7+/500 BrdU+ and 583 Pax7+/600 BrdU+, respectively,
n = 4 individual mice per genotype), suggesting that nearly all
Pax7+ cells in regenerated muscle are derived from Pax7+ satel-
lite cells that have divided during repair. To identify exactly when
Spry1 was required for satellite cell requiescence during muscle
regeneration in vivo, we injected TM into SC null and control mice
at distinct times during muscle regeneration (Figure 7A) and
quantified the number of Pax7+ satellite cells from serial sections
of uninjured and regenerated muscle (Figure 7B). TM waspry1flox/flox) muscle at 50 days after injury stained with laminin and DAPI (left).
scle (n = 4 mice per group) and expressed as mean ± SEM.
yoD (red), laminin (magenta), and DAPI (left). TUNEL+ cells are located sub- and
cated underneath the basal lamina of a regenerating muscle fiber (white arrow-
 (green) cells per muscle section. Data were averaged (4 mice per group) and
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Figure 6. Sprouty1 Regulates Reversible Quiescence of a Subset
of Satellite Cell Progenitors
(A) Primary myoblasts from Spry1WT/WT;R26R-lacZ and Spry1flox/flox:
R26R-lacZ mice were incubated with Cre adenovirus (control and Spry1Null,
respectively) and switched to low-mitogen media. Cultures were stained
with markers to determine quiescence (top; Pax7+, MyoD, Ki67), differenti-
ation (middle; Myogenin+), and apoptosis (middle; activated Caspase-3).
White arrowheads show quiescent cells; white arrows show differentiated
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124 Cell Stem Cell 6, 117–129, February 5, 2010 ª2010 Elsevier Inc.injected between 16 and 14 days prior to injury to disrupt Spry1
function in quiescent Pax7+ cells and their progeny or after injury
to target Pax7+ cells in injured muscle that had entered the cell
cycle. In regenerated muscle from TM-treated control mice,
the average number of Pax7+ cells per muscle section was not
significantly different from the contralateral uninjured muscle.
TM injected into SC null mice 14 days prior to injury resulted in
a 40% loss in the size of the Pax7+ satellite cell pool in fully regen-
erated muscle. Remarkably, a 40% loss in the size of the self-
renewed Pax7+ pool was also observed when TM was injected
into SC null mice 7–10 days after muscle injury, thus not affecting
Spry1 function in quiescent Pax7+ cells prior to injury (Figure 7B).
The result is consistent with a subset of Pax7-derived progeni-
tors providing a source of satellite cells that require Spry1
expression for their return to quiescence and homeostasis of
the self-renewing Pax7 pool. To test whether the influence of
Spry1 on restoration of the muscle stem cell pool was temporally
restricted during regeneration, we injected TM later during
muscle regeneration (10–12 or 18–20 days after injury). The
effect of Spry1 disruption at later time point was more subtle
than injections at earlier time points, reducing the number of
Pax7+ satellite cells that replenished the regenerated muscle
by30% and5%, respectively, compared to uninjured contra-
lateral muscle. The results are consistent with the critical role of
Sprouty1 in conveying temporally coordinated signals within the
regenerating muscle in a subset of Pax7+ satellite cell descen-
dents that possess self-renewal properties and are essential
for re-establishing homeostasis of the Pax7+ satellite cell pool
during repair.
We next asked whether inhibition of ERK signaling could
prevent the diminution of the quiescent Pax7+ satellite cell pool
in the absence of Spry1 during muscle regeneration. TA/EDL
muscles from Spry1+/+ and Spry1lacZ/lacZ were injured and al-
lowed to recover for 13 days. Mice were administered U0126
or vehicle via i.p. injection at 11 and 12 days after injury. The
number of quiescent Pax7+ cells increased in U0126-treated
Spry1lacZ/lacZ muscle in comparison to that observed in control
muscle (Figure 7C). Therefore, Spry1 signals through the ERK
cascade to regulate reversible quiescence of the Pax7 satellite
cell pool during muscle regeneration.
The results so far are consistent with a specific subpopulation
of quiescent Pax7-derived satellite cells requiring Spry1 for
their self-renewal. We reasoned that the self-renewing Spry1-
‘‘independent’’ Pax7+ satellite cell pool would self-renew as
effectively as Pax7-derived satellite cells from control muscles.
To test this hypothesis, we asked whether upon a second round
of injuries the Pax7+ pool in Spry1-deficient satellite cells was
diminished. At 50 days after a primary injury, TA/EDL muscle
from Spry1lacZ/lacZ, SC null and their respective control muscles(top) and apoptotic (middle) cells. Lower panel shows activated Caspase-3
staining in mononucleated MyoD+ cells.
(B and C) Histograms show (B) the percentage of quiescent Pax7+ cells (left),
percentage of apoptotic cells (right), and (C) percentage of differentiated
myogenic cells (left) and ability to fuse (right).
(D) MEK inhibitor, U0126 (3 and 10 mM) or diluent alone (DMSO (-)) was added
to Spry1flox/flox (Spry1Null) and Spry1WT/WT (control) reserve cell cultures for
2 days. Histogram shows the percentage of quiescent (Pax7+, MyoD,
Ki67) cells.
Scale bar represents 40 mm.
Figure 7. Return to Quiescence Is Temporally Instructed in a Subpopulation of Cycling Pax7 Satellite Cells
(A) Cartoon depicting the TM strategy to induce Cre activation in control (Pax7-CreERtm;Spry1WT/WT) and SC null (Pax7-CreERtm;Spry1flox/flox) mice 14 days prior
to injury or at distinct phases of muscle regeneration. Muscles were analyzed 50 days after muscle injury.
(B) Muscle sections from experiments depicted in (A) were stained with anti-Pax7, MyoD, Ki67, laminin, and DAPI. Histogram shows the average number of Pax7+
cells per muscle section in regenerated SC null muscle expressed relative to the number of Pax7+ cells in the uninjured contralateral muscle. Data were averaged
over a minimum of four mice per group and expressed as mean ± SEM.
(C) Muscles from Spry1+/+ and Spry1lacZ/lacZ adult mice were injured and left to regenerate for 13 days. Mice were treated with U0126 or vehicle (DMSO) via i.p.
injection 10 and 11 days after injury. Histograms show the number of quiescent Pax7+ satellite cells located underneath the basal lamina of muscle sections.
(D) Mice were subjected to two rounds of injury (1 and 2) and 50 days of repair. Fifty days after the second injury, muscle was analyzed for the number of Pax7+
cells in satellite cell position in Spry1+/+ and Spry1lacZ/lacZ (left) and TM-treated SC null and littermate controls (right) (**p < 0.01).
(E) The average muscle fiber size from control and SC null muscles from (D).
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a further 50 days. The number of Pax7+ satellite cells (Figure 7D)
and average muscle fiber size (Figure 7E) was not altered after a
secondary injury compared to the primary injury in Spry1 loss-of-
function mutants, similar to their controls. Together, these
results strongly suggest that Sprouty1 is essential for the return
to quiescence of a distinct subpopulation of self-renewing Pax7+
muscle stem cells during muscle regeneration.
DISCUSSION
We undertook a genetic lineage tracing analysis in combination
with a temporally inducible, cell-specific gene deletion approachCto identify the endogenous pool of adult muscle stem cells within
their native environment, as well as to determine the molecular
regulators of their self-renewal capacity during muscle regener-
ation. The results of the current study demonstrate that adult
Pax7-expressing satellite cells can contribute to both de novo
myofiber formation and restoration of the satellite cell pool
back to homeostatic levels after injury. Our studies illustrate a
novel role of the RTK inhibitor Sprouty1 (Spry1) in adult stem
cell function and tissue homeostasis. We have identified that
disruption of Spry1 in adult Pax7+ cells prevents their return to
quiescence and results in a failure to replenish the satellite cell
pool to homeostatic levels after muscle injury. Spry1 function
was limited to a subpopulation of Pax7-derived cells able toell Stem Cell 6, 117–129, February 5, 2010 ª2010 Elsevier Inc. 125
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not their differentiation potential. Together, these results demon-
strate that Spry1 is an essential regulator of quiescence and
homeostasis of the adult muscle stem cell pool during muscle
regeneration.
Genetic lineage tracing approaches offer an alternative method
to transplantation assays to track endogenous stem cell popula-
tions and their functional potential within their native environment.
Lineage tracing experiments have shown that nearly all (>90%)
adult quiescent satellite cells have expressed transcription
factors Pax3, Myf5, MyoD, and Pax7 at some point during their
developmental history (Schienda et al., 2006; Kuang et al., 2007;
Kanisicak et al., 2009; Lepper et al., 2009; Brack et al., 2009).
By using an inducible Pax7 Cre allele, it was recently shown that
adult Pax7+ satellite cells are capable of contributing to muscle
fiber repair after multiple rounds of injury, thus demonstrating their
stem cell potential (Lepper et al., 2009). By using a different induc-
ible Pax7-Cre allele (Nishijo et al., 2009), we demonstrate that
upon barium chloride-induced muscle injury, Pax7-derived cells
contribute tomyofiberdifferentiationand fully restore the renewed
satellite cell pool back to homeostasis during repair.
We demonstrate that Spry1, an inhibitor of growth factor sig-
naling, is robustly and preferentially expressed in Pax7+ cells in
their quiescent state in uninjured and regenerating muscle
in vivo, suggesting that Spry1 is a marker of Pax7+ satellite cells
in their quiescent state (Fukada et al., 2007). Low levels of Spry1
expression could be observed in subsets of nascent myotubes
in vivo and in vitro (data not shown) as shown previously (Laziz
et al., 2007). This probably reflects that Spry genes are activated
in the presence of growth factors within the extrinsic milieu and
that differentiated myotubes can respond to growth factor
signals (Perez-Ruiz et al., 2007). That Spry1 expression is
elevated and sustained in quiescent Pax7+ cells compared to
either cycling Pax7+ cells or differentiating myogenic cells
suggests specificity in Spry1 signaling components within
myogenic cells of different fates.
The ability of a cell to undergo reversible quiescence is critical
for maintenance of the stem cell pool (Sang et al., 2008). Deple-
tion of the stem cell pool is often observed in conditions of main-
tained proliferation (Orford and Scadden, 2008) and may explain
the diminution of the satellite cell pool observed in muscular
dystrophies (Bockhold et al., 1998; Cerletti et al., 2008). The
mechanism controlling satellite cell self-renewal and the return
to quiescence after proliferation remains incompletely under-
stood. Satellite cell heterogeneity (Kuang et al., 2007), asym-
metric inheritance of fate determinants (Conboy et al., 2007;
Shinin et al., 2009), and modulation of signaling cascades such
as Notch, Wnt, and MAPK pathways (Jones et al., 2005; Kuang
et al., 2007; Perez-Ruiz et al., 2008; Abou-Khalil et al., 2009)
have all been proposed to control self-renewal. Precise control
of growth factor-sensitive MAPK/RTK signaling is critical for
myogenic fate decisions (Allen et al., 1984; Clegg et al., 1987;
Fedorov et al., 1998; Jones et al., 2001). We propose that cycling
muscle stem cells traverse through a growth factor-mediated
checkpoint prior to returning to quiescence and in the absence
of Spry1 instead appropriate an apoptotic fate decision leading
to a diminished pool of muscle stem cells.
Disruption of Spry1 in all cells or specifically in adult Pax7+
satellite cells in vivo did not affect the formation or maintenance126 Cell Stem Cell 6, 117–129, February 5, 2010 ª2010 Elsevier Inc.of the satellite cell pool under homeostatic conditions; however,
during muscle regeneration, the renewed Pax7+ satellite cell
pool did not return back to homeostatic levels but instead was
50% smaller. In addition, targeting a heterogeneous population
(Pax7-expressing and nonexpressing) of myogenic progenitors
in vitro led to a 50% reduction in cells that returned to quies-
cence in vitro. Together these data favor the hypothesis that
Spry1 is a major regulator of reversible quiescence and the ability
of Pax7-derived satellite cells to self-renew. Furthermore, the
data also strongly suggest that there is a level of heterogeneity
within the renewing Pax7+ satellite cell compartment, whereby
50% of the Pax7+ satellite cell pool does not require Spry1 for
its renewal capability. By using a paradigm of repeated injuries
to test self-renewal potential, we demonstrate that the remaining
(‘‘Spry1-independent’’) population of Pax7-derived satellite cells
has self-renewal potential, although this subpopulation of Pax7+
cells is not sufficient or maybe not required to restore the pool of
satellite cells back to levels observed prior to injury. Further
experiments are required to determine the functional differences
between the distinct ‘‘Spry1-dependent’’ and ‘‘Spry1-indepen-
dent’’ populations.
A reciprocal balance between self-renewal and differentiation
within a stem cell compartment is indicative of a single popula-
tion of stem cells. Disruption of Spry1 in Pax7+ cells affected
the ability of the stem cell pool to renew; however, we did not
observe any reciprocal changes or alterations in the cells’ ability
to differentiate either in vitro or in vivo. This suggests that Spry1
function contributes to define the molecular heterogeneity in
adult satellite cells. Muscle stem cell functional heterogeneity
has been proposed based on satellite cells that progressed
through a Myf5 lineage during their developmental history
(Kuang et al., 2007). Adult satellite cells that have not previously
expressed Myf5, based on a readout from a Myf5 Cre reporter,
had a greater self-renewal capacity, compared to satellite cells
from a Myf5 ancestry that had a greater capacity to differentiate.
Disruption of Spry1 within Pax7-derived satellite cells markedly
affected their self-renewing potential, but not their differentia-
tion, consistent with a requirement for Spry1 in a subpopulation
of satellite cells that have high self-renewal potential but low
differentiating potential. An alternative but not mutually exclusive
hypothesis is that other Spry family members or other signaling
pathways, such as the noncanonical Wnt cascade (Le Grand
et al., 2009), coordinate to control self-renewal and differentia-
tion, providing a level of heterogeneity and maybe cellular spec-
ificity at the level of the signaling pathway.
The coordination of cell fate decisions involving proliferation
and subsequent differentiation of myogenic progenitors during
muscle regeneration are controlled through an antagonistic rela-
tionship between Notch and canonical Wnt signaling (Brack
et al., 2008). The re-expression of Spry1 and the return to quies-
cence of Pax7+ satellite cell population in a coordinated manner
during muscle regeneration raised the possibility that requies-
cence of the renewing stem cell pool was also coordinated in a
stage-specific manner, occurring principally after the majority
of satellite cell proliferation and early stages of differentiation
has occurred. We speculate that Spry genes may fine-tune the
dosage and/or duration of extrinsic signals within regenerating
tissue to determine stem cell fate decisions for effective tissue
homeostasis and repair.
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Sprouty1, a gene essential for embryonic cell fate determination,
is an essential regulator of adult muscle stem quiescence and
homeostasis of the self-renewing muscle stem cell pool during
regeneration.
EXPERIMENTAL PROCEDURES
Animals
Mice carrying the Spry1 gene flanked by a pair of loxP sites (Spry1flox) were
used for tissue-specific deletion studies (Basson et al., 2005). Mice with two
copies of Spry1flox or with wild-type Spry1 (Spry1WT) were crossed with
Pax7-CreERtm;Spry1flox/+ mice (Nishijo et al., 2009) to generate Pax7-
CreERtm;Spry1flox/flox (Satellite cell- specific Spry1Null [SC null]) and control
littermates. Experimental animals were maintained on a CD1 background.
Mice were bred to heterozygosity for Pax7-CreERtm and homozygosity with
the R26R-lacZ reporter (Soriano, 1999). Spry1lacZ mice were maintained on
a FVB background (Thum et al., 2008). Animals were housed and handled in
accordance with the guidelines of the MGH subcommittee for animal research.
Muscle Injury
Injury to whole TA/EDL muscle was made by injection of barium chloride (50 ml,
1.2%) into 30 sites in the lower limb. This produced an extensive injury result-
ing in homogenous damage and activation of satellite cells. A single intraper-
itoneal (i.p.) injection of BrdU (6 mg/gram mouse) was given followed by BrdU
administered ad libitum in drinking water (2.5 mg/ml) for 7–12 days. Muscles
were subjected to a secondary injury (50 ml, 1.2% of barium chloride) 50
days after an initial injury and allowed to recover for a further 50 days. For
in vivo manipulation of ERK signaling, U0126 (30 mg/kg diluted in 5%
DMSO/PBS) or diluent alone (Schuh and Pahl, 2009) was administered via
i.p. injection 11 and 12 days after initial muscle injury.
Myogenic Cell Preparation
Single-fiber cultures and satellite cell isolations were performed as described
previously (Zammit et al., 2004; Brack et al., 2007). To generate ‘‘reserve cell’’
cultures (Yoshida et al., 1998), low-passage primary myoblasts were main-
tained in growth media (20% FBS, 5 ng/ml bFGF in Ham’s F-10 [Mediatech])
and switched to differentiation media (3% HS in DMEM) for 3.5 days at high
density (80%–90% confluency). U0126 was added to cultures every 20 hr.
Activation of Cre Recombinase
Low-passage myoblasts were infected with adenovirus Ad5CMVCre-eGFP or
Ad5CMV-eGFP-control (Gene Transfer Vector Core, University of Iowa)
(diluted 1:1000 in growth media from a stock titer of 1 3 1010 pfu/ml) for
1.5 hr at 37C. Cells were washed in PBS and incubated in fresh growth media
for 18 hr and either fixed or replated in growth media at equal density for 24 hr
and switched to fusion media for 1–4 days. Mice aged 3–4 months were given
intraperitoneal (i.p.) injections of tamoxifen (TM) (300 ml, 10 mg/ml, diluted in
corn oil [Sigma]) daily for 3 days either prior to (12–14 days) or after (ranging
from 7–9 to 18–20 days) injury.
Histology and Immunoflourescence
Muscles were dissected and embedded for cryostat sectioning as previously
described (Brack et al., 2007). For analysis of b-gal activity, TA muscle was
fixed in 2% PFA/0.2% gluteraldehyde and prepared as described previously
(Brack et al., 2007). Tissue sections for immunohistochemistry were fixed in
4% PFA for 10 min, washed, permeabilized in 0.2% PBT, and incubated in
M.O.M. blocking reagent (10%, Vector) for 30 min and then in 1% MOM,
10% GS/PBT, for 30 min. Sections were stained in Pax7 antibody overnight
at 4C. To reduce background staining of mouse antibody on regenerating
mouse tissue, sections were washed, blocked, and incubated in a ‘‘bridging
antibody’’ (rat anti-mouse IgG) at 1/500 for 3 hr at room temperature in addition
to rabbit anti-MyoD, rabbit anti-Ki67, and chick anti-Laminin primary anti-
bodies. Sections were washed, blocked, and incubated in Alexa fluorophore
conjugated species-specific anti-IgG antibodies with DAPI for 1 hr at room
temperature. Tissue sections for BrdU detection were fixed in 4% PFA,
washed in PBS, and then antigen-retrieved with sodium citrate (10 mM,C0.05% Tween in PBS) at 95C for 30 min. Sections were washed in PBS for
30 min and blocked in 10% GS/PBT then incubated with anti-mouse Pax7
and anti-rat BrdU overnight at 4C and secondary antibodies as described
above. Immunofluorescence was performed on fixed cells and fibers (4%
PFA, 10 min) after permeabilization (0.2% PBT; 10 min) and block (10% goat
serum [GS] in PBT). Cells were incubated in primary antibodies overnight at
4C. Cells were washed and blocked in 5% GS/PBT then incubated in Alexa
fluorophore-conjugated antibodies and DAPI to visualize nuclei for 1 hr at
room temperature. Antibodies and concentrations used are provided in
Supplemental Information. Methods describing the quantification of muscle
regeneration is provided in Supplemental Information.
Fluorescent-Activated Cell Sorting
To obtain highly purified myogenic cells, mononucleated cells were isolated
from uninjured and regenerating muscle as described (Brack et al., 2009)
with modifications. Cells were incubated in Sorting media (5% FBS, 10%
BlokHen in Hams F10) for 10 min then incubated in anti-chick-Syn4 and
anti-mouse-integrin-a7 for 20 min. Cells were washed in sorting media and
spun at 1500 rpm for 5 min. Cells were stained in CD31-PE, CD45-PE,
anti-chick Alexa688, and anti-mouse Alexa488 for 20 min. Myogenic cells
had the following profile: Syn-4+, Integrin-a7+,CD31,CD45,PI. Cells were
sorted with FACS Aria (BD Biosciences). Protocol modified from Sacco et al.
(2008) and Brack et al. (2009). Sorted cells for immunohistochemical analysis
were cytospun immediately after collection. Description of western blotting is
provided in Supplemental Information.
Real-Time RT-PCR
Approximately 30,000 FACS-sorted cells were collected from either uninjured
or regenerating muscle and prepared for qRT-PCR analysis. First-strand cDNA
was directly synthesized from each cell lysate by the SuperScript III CellsDirect
cDNA Synthesis Kit (Invitrogen). Quantitative real-time PCR was performed on
the Mx3000P qPCR system (Stratagene), with Brilliant SYBR Green qPCR
master mix (Stratagene) with primers against Spry1 and GAPDH. Primers
and thermal cycler conditions are detailed in the Supplemental Information.
Analysis of genomic recombination of Spry1 open reading frame was per-
formed by PCR (Basson et al., 2005).
Statistical Analysis
A minimum of three and up to six replicates was done for all experiments
presented. Data are presented as means and standard errors of the mean.
Comparisons between groups were done via a one-way analysis of variance
and a Tukey post hoc test. Comparisons within groups were done with a t test
with repeated-measures. Differences were considered statistically significant
at the p < 0.05 level.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at doi:10.1016/j.
stem.2009.12.015.
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